Annual report
7129.TEDINET S100R6MQ
Period2022-04-01 → 2023-03-31
Filed2023-06-28
StandardJapan GAAP
ConsolidatedYes
Data checks22 of 22 passed
Key figures · 74
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥22.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥19.5bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Operating income | ¥191m | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥186m | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥169m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥190m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥348m | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥534m | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥210m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥292m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥210m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥292m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥14.1bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥14.2bn | at 2022-03-31 | Cons. | Assets |
| Total liabilities | ¥10.8bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥11.0bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥3.3bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.2bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.0bn | at 2021-03-31d | Cons. | Net assets |
| Cash and deposits | ¥1.3bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.1bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.2bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥691m | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥919m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥557m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.5bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥369m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥2.0bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥84.22 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥117.49 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥83.84 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥116.61 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥1,341.2 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,287.13 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 23.6% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.5% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 6.4% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.4% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,782 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 1,752 | at 2022-03-31 | Cons. | Number of employees |
| Revenue | ¥278m | 2022-04-01 → 2023-03-31 | Standalone | Operating revenue1 |
| Revenue | ¥116m | 2021-04-01 → 2022-03-31 | Standalone | Operating revenue1 |
| Operating income | ¥85m | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | ¥52m | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | ¥90m | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥52m | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Profit before tax | ¥90m | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥52m | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | ¥60m | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥62m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Total assets | ¥3.2bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥3.1bn | at 2022-03-31 | Standalone | Assets |
| Total liabilities | ¥141m | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥71m | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥3.1bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥3.1bn | at 2022-03-31 | Standalone | Net assets |
| Cash and deposits | ¥32m | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥3m | at 2022-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥24.16 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥24.86 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥24.06 | 2022-04-01 → 2023-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥24.68 | 2021-04-01 → 2022-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥30 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥17 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,226.96 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,232.94 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 95.6% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 97.7% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 2.0% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 2.0% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 2,488,700 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,488,300 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 92
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2022-04-01 → 2023-03-31 | ¥540,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2022-04-01 → 2023-03-31 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2023-03-31 | 21 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2023-03-31 | ¥974m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2023-03-31 | ¥945m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥29m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2023-03-31 | ¥180m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2023-03-31 | ¥48m |
| Reconciling Itemsreconciling | capex | 2022-04-01 → 2023-03-31 | ¥13m |
| Reconciling Itemsreconciling | depreciation | 2022-04-01 → 2023-03-31 | ¥43m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2023-03-31 | −¥29m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2023-03-31 | −¥29m |
| Reconciling Itemsreconciling | segment assets | at 2023-03-31 | ¥2.0bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2023-03-31 | −¥778m |
| Medicine Businessreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥103m |
| Medicine Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥88m |
| Medicine Businessreportable segment | employees | at 2023-03-31 | 199 pure |
| Medicine Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥9.0bn |
| Medicine Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥9.0bn |
| Medicine Businessreportable segment | segment assets | at 2023-03-31 | ¥2.9bn |
| Medicine Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥531m |
| Nursing Care Businessreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥8m |
| Nursing Care Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥45m |
| Nursing Care Businessreportable segment | employees | at 2023-03-31 | 296 pure |
| Nursing Care Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥3.4bn |
| Nursing Care Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥3.4bn |
| Nursing Care Businessreportable segment | segment assets | at 2023-03-31 | ¥1.1bn |
| Nursing Care Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | −¥147m |
| Nurturing Businessreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥515m |
| Nurturing Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥400m |
| Nurturing Businessreportable segment | employees | at 2023-03-31 | 1219 pure |
| Nurturing Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥8.9bn |
| Nurturing Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥8.9bn |
| Nurturing Businessreportable segment | segment assets | at 2023-03-31 | ¥7.8bn |
| Nurturing Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥537m |
| —segment total | capex | 2022-04-01 → 2023-03-31 | ¥626m |
| —segment total | depreciation | 2022-04-01 → 2023-03-31 | ¥533m |
| —segment total | revenue | 2022-04-01 → 2023-03-31 | ¥21.3bn |
| —segment total | revenue external | 2022-04-01 → 2023-03-31 | ¥21.3bn |
| —segment total | segment assets | at 2023-03-31 | ¥11.9bn |
| —segment total | segment profit | 2022-04-01 → 2023-03-31 | ¥921m |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-04-01 → 2023-03-31 | ¥626m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-04-01 → 2023-03-31 | ¥536m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2023-03-31 | ¥22.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2023-03-31 | ¥22.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥29m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-03-31 | ¥12.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2023-03-31 | ¥970m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2021-04-01 → 2022-03-31 | ¥237,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2021-04-01 → 2022-03-31 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2022-03-31 | ¥932m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2022-03-31 | ¥905m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥27m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2022-03-31 | ¥165m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2022-03-31 | ¥39m |
| Reconciling Itemsreconciling | capex | 2021-04-01 → 2022-03-31 | ¥218m |
| Reconciling Itemsreconciling | depreciation | 2021-04-01 → 2022-03-31 | ¥42m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2022-03-31 | −¥27m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2022-03-31 | −¥27m |
| Reconciling Itemsreconciling | segment assets | at 2022-03-31 | ¥2.0bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2022-03-31 | −¥798m |
| Medicine Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥175m |
| Medicine Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥68m |
| Medicine Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥8.8bn |
| Medicine Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥8.8bn |
| Medicine Businessreportable segment | segment assets | at 2022-03-31 | ¥2.9bn |
| Medicine Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥559m |
| Nursing Care Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥69m |
| Nursing Care Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥55m |
| Nursing Care Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥3.4bn |
| Nursing Care Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥3.4bn |
| Nursing Care Businessreportable segment | segment assets | at 2022-03-31 | ¥1.2bn |
| Nursing Care Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥25m |
| Nurturing Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥2.6bn |
| Nurturing Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥307m |
| Nurturing Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥6.4bn |
| Nurturing Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥6.4bn |
| Nurturing Businessreportable segment | segment assets | at 2022-03-31 | ¥7.8bn |
| Nurturing Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥362m |
| —segment total | capex | 2021-04-01 → 2022-03-31 | ¥2.9bn |
| —segment total | depreciation | 2021-04-01 → 2022-03-31 | ¥430m |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥18.6bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥18.6bn |
| —segment total | segment assets | at 2022-03-31 | ¥12.0bn |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | ¥946m |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-04-01 → 2022-03-31 | ¥2.9bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-04-01 → 2022-03-31 | ¥434m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2022-03-31 | ¥19.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2022-03-31 | ¥19.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥27m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-03-31 | ¥12.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2022-03-31 | ¥985m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,258
| Item | Context | Value | Unit |
|---|---|---|---|
| Lease assets net ppe | CurrentYearInstant | 256591000 | JPY |
| Construction in progress | Prior1YearInstant | 31361000 | JPY |
| Construction in progress | CurrentYearInstant | 25058000 | JPY |
| Other net ppe | Prior1YearInstant | 177000 | JPY |
| Other net ppe | CurrentYearInstant | 0 | JPY |
| Property plant and equipment | Prior1YearInstant | 6777168000 | JPY |
| Property plant and equipment | CurrentYearInstant | 6764858000 | JPY |
| Leasehold right | Prior1YearInstant | 204360000 | JPY |
| Leasehold right | CurrentYearInstant | 204360000 | JPY |
| Software | Prior1YearInstant | 38385000 | JPY |
| Software | CurrentYearInstant | 27113000 | JPY |
| Goodwill | Prior1YearInstant | 351691000 | JPY |
| Goodwill | CurrentYearInstant | 278840000 | JPY |
| Other ia | Prior1YearInstant | 299000 | JPY |
| Other ia | CurrentYearInstant | 74000 | JPY |
| Intangible assets | Prior1YearInstant | 594737000 | JPY |
| Intangible assets | CurrentYearInstant | 510389000 | JPY |
| Long term prepaid expenses | Prior1YearInstant | 142568000 | JPY |
| Long term prepaid expenses | CurrentYearInstant | 124231000 | JPY |
| Deferred tax assets | Prior1YearInstant | 10117000 | JPY |
| Deferred tax assets | CurrentYearInstant | 6656000 | JPY |
| Guarantee deposits ioa | Prior1YearInstant | 1089935000 | JPY |
| Guarantee deposits ioa | CurrentYearInstant | 1034869000 | JPY |
| Real estate for investment net | Prior1YearInstant | 189650000 | JPY |
| Real estate for investment net | CurrentYearInstant | 179549000 | JPY |
| Other ioa | Prior1YearInstant | 506972000 | JPY |
| Other ioa | CurrentYearInstant | 465444000 | JPY |
| Investments and other assets | Prior1YearInstant | 1939244000 | JPY |
| Investments and other assets | CurrentYearInstant | 1810751000 | JPY |
| Noncurrent assets | Prior1YearInstant | 9311150000 | JPY |
| Noncurrent assets | CurrentYearInstant | 9085998000 | JPY |
| Assets | Prior1YearInstant | 14205288000 | JPY |
| Assets | CurrentYearInstant | 14135911000 | JPY |
| Accounts payable trade | Prior1YearInstant | 2354677000 | JPY |
| Accounts payable trade | CurrentYearInstant | 2347151000 | JPY |
| Short term loans payable | Prior1YearInstant | 1735000000 | JPY |
| Short term loans payable | CurrentYearInstant | 2090000000 | JPY |
| Current portion of bonds | Prior1YearInstant | 41000000 | JPY |
| Current portion of bonds | CurrentYearInstant | 31000000 | JPY |
| Current portion of long term loans payable | Prior1YearInstant | 642556000 | JPY |
| Current portion of long term loans payable | CurrentYearInstant | 616932000 | JPY |
| Lease obligations cl | Prior1YearInstant | 37740000 | JPY |
| Lease obligations cl | CurrentYearInstant | 37666000 | JPY |
| Accounts payable other | Prior1YearInstant | 255782000 | JPY |
| Accounts payable other | CurrentYearInstant | 287113000 | JPY |
| Accrued expenses | Prior1YearInstant | 542152000 | JPY |
| Accrued expenses | CurrentYearInstant | 558886000 | JPY |
| Income taxes payable | Prior1YearInstant | 20139000 | JPY |
| Income taxes payable | CurrentYearInstant | 59659000 | JPY |
| Deposits received | Prior1YearInstant | 56922000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 22 of 22 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |